ATE137407T1 - Behandlung von intraocularem druck mit einer synergistischen kombination - Google Patents

Behandlung von intraocularem druck mit einer synergistischen kombination

Info

Publication number
ATE137407T1
ATE137407T1 AT92301412T AT92301412T ATE137407T1 AT E137407 T1 ATE137407 T1 AT E137407T1 AT 92301412 T AT92301412 T AT 92301412T AT 92301412 T AT92301412 T AT 92301412T AT E137407 T1 ATE137407 T1 AT E137407T1
Authority
AT
Austria
Prior art keywords
synergistic combination
intraocular pressure
treatment
treating intraocular
pharmaceutically acceptable
Prior art date
Application number
AT92301412T
Other languages
German (de)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of ATE137407T1 publication Critical patent/ATE137407T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92301412T 1991-03-01 1992-02-20 Behandlung von intraocularem druck mit einer synergistischen kombination ATE137407T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6132891 1991-03-01

Publications (1)

Publication Number Publication Date
ATE137407T1 true ATE137407T1 (de) 1996-05-15

Family

ID=13167964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92301412T ATE137407T1 (de) 1991-03-01 1992-02-20 Behandlung von intraocularem druck mit einer synergistischen kombination

Country Status (11)

Country Link
US (1) US5547968A (OSRAM)
EP (1) EP0501678B1 (OSRAM)
JP (1) JP2511611B2 (OSRAM)
KR (1) KR100221369B1 (OSRAM)
AT (1) ATE137407T1 (OSRAM)
CA (1) CA2061907C (OSRAM)
DE (1) DE69210286T2 (OSRAM)
DK (1) DK0501678T3 (OSRAM)
ES (1) ES2089387T3 (OSRAM)
GR (1) GR3019820T3 (OSRAM)
TW (1) TW210287B (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2270349A1 (en) * 1996-11-01 1998-05-14 Jesse A. May Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
TWI643619B (zh) * 2012-07-13 2018-12-11 日商參天製藥股份有限公司 一種用於預防或治療青光眼或高眼壓症、或降低眼壓之醫藥組合物及其用途
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
ES2042625T5 (es) * 1987-04-03 2000-07-16 Univ Columbia Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
EP0580268B1 (en) * 1988-10-01 1998-01-14 R-Tech Ueno Ltd. Ocular hypotensive agents

Also Published As

Publication number Publication date
KR920017654A (ko) 1992-10-21
DE69210286D1 (de) 1996-06-05
US5547968A (en) 1996-08-20
ES2089387T3 (es) 1996-10-01
JPH0565227A (ja) 1993-03-19
TW210287B (OSRAM) 1993-08-01
EP0501678B1 (en) 1996-05-01
DK0501678T3 (da) 1996-05-28
JP2511611B2 (ja) 1996-07-03
GR3019820T3 (en) 1996-08-31
KR100221369B1 (ko) 1999-09-15
CA2061907A1 (en) 1992-09-02
DE69210286T2 (de) 1996-09-12
EP0501678A3 (en) 1992-12-16
EP0501678A2 (en) 1992-09-02
CA2061907C (en) 2003-04-08

Similar Documents

Publication Publication Date Title
ATE178801T1 (de) Tgf-beta zur verbesserung der regeneration von neuronalem gewebe
SE9103612D0 (sv) New peptide derivatives
PT646012E (pt) Cura de feridas e tratamento de perturbacoes fibroticas por tgfbeta-3
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
MX9204381A (es) Metodo para tratar inflamacion ocular
ATE175875T1 (de) Tirilazad parentale formulierung mit einem co- lösungsmittel
FI875308A0 (fi) Foerfarande i tvao steg foer att hela ett saor smaertfritt och ett vattenhaltigt medium och en salva foer lokal anvaendning vid foerfarandet.
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE69105349D1 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
ATE137407T1 (de) Behandlung von intraocularem druck mit einer synergistischen kombination
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ATE117208T1 (de) Behandlung von intraokularem druck mit einer ophthalmischen synergistischen kombination.
ATE132750T1 (de) Behandlung von intraokularem druck mit einer synergischen kombination
ATE175927T1 (de) Verfahren zum verbessern von eisenbahnrädern
SE9403160D0 (sv) Method and means for prevention and treatment of secondary cataract
DE69301387D1 (de) Behandlung des Glaukoms mit synergistischer Kombination
ATE91419T1 (de) Synergistische kombination zur ophthalmischen verwendung.
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
MY129918A (en) Method for treating hypertension.
MY118982A (en) Method of reducing tissue damage associated with ischemia
UA10079A (uk) Спосіб лікування пародонтиту
UA26224C2 (uk) Спосіб підготовки hасіhhя цукрового буряку до сівби
UA10000A (uk) Спосіб лікування гострої недостатності тканинного дихання

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee